Literature DB >> 19671765

HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells.

Rajesh R Nair1, Michael F Emmons, Anne E Cress, Raul F Argilagos, Kit Lam, William T Kerr, Hong-Gong Wang, William S Dalton, Lori A Hazlehurst.   

Abstract

HYD1 is a D-amino acid peptide that was previously shown to inhibit adhesion of prostate cancer cells to the extracellular matrix. In this study, we show that in addition to inhibiting adhesion of multiple myeloma (MM) cells to fibronectin, HYD1 induces cell death in MM cells as a single agent. HYD1-induced cell death was necrotic in nature as shown by: (a) decrease in mitochondrial membrane potential (Deltapsi(m)), (b) loss of total cellular ATP, and (c) increase in reactive oxygen species (ROS) production. Moreover, HYD1 treatment does not result in apoptotic cell death because it did not trigger the activation of caspases or the release of apoptosis-inducing factor and endonuclease G from the mitochondria, nor did it induce double-stranded DNA breaks. HYD1 did initiate autophagy in cells; however, autophagy was found to be an adaptive response contributing to cell survival rather than the cause of cell death. We were further able to show that N-acetyl-L-cysteine, a thiol-containing free radical scavenger, partially protects MM cells from HYD1-induced death. Additionally, N-acetyl-L-cysteine blocked HYD1-induced as well as basal levels of autophagy, suggesting that ROS can potentially trigger both cell death and cell survival pathways. Taken together, our data describe an important role of ROS in HYD1-induced necrotic cell death in MM cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671765      PMCID: PMC2761715          DOI: 10.1158/1535-7163.MCT-09-0113

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  36 in total

1.  Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.

Authors:  Y Nefedova; T H Landowski; W S Dalton
Journal:  Leukemia       Date:  2003-06       Impact factor: 11.528

2.  Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization.

Authors:  Damien Arnoult; Brigitte Gaume; Mariusz Karbowski; Juanita C Sharpe; Francesco Cecconi; Richard J Youle
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

3.  Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.

Authors:  I B DeRoock; M E Pennington; T C Sroka; K S Lam; G T Bowden; E L Bair; A E Cress
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

Authors:  X Liu; H Zou; C Slaughter; X Wang
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells.

Authors:  L A Hazlehurst; N Valkov; L Wisner; J A Storey; D Boulware; D M Sullivan; W S Dalton
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

6.  3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes.

Authors:  P O Seglen; P B Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

Review 7.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle.

Authors:  Paul S Brookes; Yisang Yoon; James L Robotham; M W Anders; Shey-Shing Sheu
Journal:  Am J Physiol Cell Physiol       Date:  2004-10       Impact factor: 4.249

8.  Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans.

Authors:  Xiaochen Wang; Chonglin Yang; Jijie Chai; Yigong Shi; Ding Xue
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

9.  Human topoisomerase IIalpha nuclear export is mediated by two CRM-1-dependent nuclear export signals.

Authors:  Joel G Turner; Roxanne Engel; Jennifer A Derderian; Richard Jove; Daniel M Sullivan
Journal:  J Cell Sci       Date:  2004-06-01       Impact factor: 5.285

10.  Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis.

Authors:  M Leist; B Single; A F Castoldi; S Kühnle; P Nicotera
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

View more
  22 in total

Review 1.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

2.  Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.

Authors:  Michael F Emmons; Anthony W Gebhard; Rajesh R Nair; Rachid Baz; Mark L McLaughlin; Anne E Cress; Lori A Hazlehurst
Journal:  Mol Cancer Ther       Date:  2011-10-06       Impact factor: 6.261

3.  REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER.

Authors:  Sandeep Sreevalsan; Stephen Safe
Journal:  Curr Colorectal Cancer Rep       Date:  2013-12

4.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

5.  Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.

Authors:  Li Yin; Michio Kosugi; Donald Kufe
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

Review 6.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

7.  A preclinical assay for chemosensitivity in multiple myeloma.

Authors:  Zayar P Khin; Maria L C Ribeiro; Timothy Jacobson; Lori Hazlehurst; Lia Perez; Rachid Baz; Kenneth Shain; Ariosto S Silva
Journal:  Cancer Res       Date:  2013-12-05       Impact factor: 12.701

8.  MTI-101 (cyclized HYD1) binds a CD44 containing complex and induces necrotic cell death in multiple myeloma.

Authors:  Anthony W Gebhard; Priyesh Jain; Rajesh R Nair; Michael F Emmons; Raul F Argilagos; John M Koomen; Mark L McLaughlin; Lori A Hazlehurst
Journal:  Mol Cancer Ther       Date:  2013-09-18       Impact factor: 6.261

Review 9.  Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma.

Authors:  Nagaraju Anreddy; Lori A Hazlehurst
Journal:  J Cell Biochem       Date:  2016-06-21       Impact factor: 4.429

Review 10.  Tumor-targeting peptides from combinatorial libraries.

Authors:  Ruiwu Liu; Xiaocen Li; Wenwu Xiao; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2016-05-19       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.